A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma

Karl D. Lewis, Wolfram Samlowski, John Ward, Joseph Catlett, Lee Cranmer, John Kirkwood, David Lawson, Eric Whitman, Rene Gonzalez

Research output: Contribution to journal › Article › peer-review

119 Scopus citations

Fingerprint

Dive into the research topics of 'A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry